PMCPA issues additional draft working document to support the Consultation on the proposed 2021 ABPI Code of Practice for the Pharmaceutical Industry

Press Release 23 July 2020

The ABPI consultation on the proposed changes to the Code was issued last month.  The closing date is 8 September 2020.

The PMCPA website includes additional documents, with one to be added at a later date.  A  Draft working document of the proposed 2021 Code with tracked changes indicating the source of the content is now available.

To access the consultation directly please use this link.


Notes to Editors:

For more information contact Elly Button  07920 863650

The Prescription Medicines Code of Practice Authority (PMCPA) was established by The Association of the British Pharmaceutical Industry (ABPI) to operate the ABPI Code of Practice for the Pharmaceutical Industry independently of the ABPI. The PMCPA is a division of the ABPI. The Code covers the promotion of medicines for prescribing to health professionals and the provision of information to the public about prescription only medicines. If you have any concerns about the activities of pharmaceutical companies in this regard please contact the PMCPA at 7th Floor, 105 Victoria St London SW1E 6QT or The Code and other information, including details about ongoing cases, can be found on the PMCPA